Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CytoMed Therapeutics Limited - Ordinary Shares (NQ:GDTC)

2.570 -0.120 (-4.46%)
Streaming Delayed Price Updated: 3:49 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CytoMed Therapeutics Limited - Ordinary Shares

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Singapore’s Journey to Becoming a Biotech Powerhouse
Singapore's Biotech Vision: From 2000 Onwards In 2000, Singapore embarked on an ambitious mission to establish itself as a leading 
Via Spotlight Growth
Topics Economy
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
CytoMed Expands Research Collaboration into China After Entering Into MOU
Via ACCESSWIRE
Singapore’s Leap into the Future of Cell and Gene Therapies
Singapore is making remarkable progress in the realm of cell and gene therapy (CGT), as evidenced by the inauguration of 
Via Spotlight Growth
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a... 
Via Talk Markets
The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology
CytoMed Therapeutics, a NASDAQ-listed company (Stock Symbol: GDTC), is at the forefront of a revolution in cellular therapy for cancers. 
Via Spotlight Growth
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday. 
Via Benzinga
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.40% to 34,080.13 while the NASDAQ rose 0.23% to... 
Via Benzinga
Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today?
Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering. 
Via InvestorPlace
Why Is EzFill (EZFL) Stock Down 5% Today?
EzFill (EZFL) stock is taking a beating on Tuesday despite the company releasing positive data from the second quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment. 
Via InvestorPlace
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. 
Via Benzinga
Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
CytoMed Therapeutics (GDTC) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
CytoMed Therapeutics Collaborates With Cancer Treatment Center to Advance Its Unique CAR-T Technology
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
CytoMed (NASDAQ: GDTC): Revolutionizing Cancer Treatment with Unique CAR-T Cell Technology
Despite the substantial advances in medical technology, cancer remains a formidable foe with an alarming annual growth rate. According to 
Via Spotlight Growth
J&J's Kenvue Jumps 20% In Market Debut
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known... 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.